Navigation Links
GeneNews announces 2007 year end results
Date:3/26/2008

loss for the quarter ended December 31, 2007 was $2.6 million or ($0.05) per common share compared with a net loss of $2.7 million or ($0.05) per common share for the same period last year. The net loss is reflective of the Company's continuing focus on research and development and the process leading to commercialization of its first product ColonSentry(TM), a convenient and patient-friendly blood-based test that can assess a patient's current risk for colon cancer, and the advancement of related products in the Company's pipeline.

Financial results (CDN dollars) for the year-ended December 31, 2007:

Total revenue for the year-ended December 31, 2007 was $2.2 million compared with $3.3 million for the same period last year. Of the revenues in 2007, $0.2 resulted from the prostate disease biomarker development agreement and $1.7 representing the final revenue from a collaboration agreement with Pfizer. In 2006, revenues resulted entirely from the Pfizer agreement.

Interest earned during the year-end ended December 31, 2007 was $822,000, compared to $448,000 for the corresponding period during the prior year.

Total operating expenditures for the year-ended December 31, 2007 were $12.6 million compared with $12.7 million for the same period last year. Research and development expenses for the quarter were $8.9 million compared with $9.5 million for the same period last year. General and administrative expenses for the year-ended December 31, 2007 were $2.7 million compared with $1.9 million for the corresponding period in 2006.

The net loss for the year-ended December 31, 2007 was $9.6 million or ($0.17) per common share compared to a net loss of $8.9 million or ($0.18) per common share for the same period last year. The Company's continuing focus is on research and development leading to commercialization of its first product and the development of related products in the Company's pipeline.

As at December 31, 2007, the Compa
'/>"/>

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Diego, CA (PRWEB) October 30, 2014 ... announced today that they have manually curated public data ... and non profit customers. the data is now ... manually curates and unifies public and internal data sources ... value and knowledge out of the data that becomes ...
(Date:10/30/2014)... Spartan Bioscience announced today that Health ... . It detects CYP2C19 genetic mutations in less than ... Spartan RX CYP2C19 System is the first near-patient DNA ... Canada. Due to the system’s ease of use, Health ... healthcare professionals such as doctors, nurses, pharmacists, and laboratory ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Avure Technologies celebrates ... 525L, the newest member of its fleet of high volume ... reaching an anniversary as we return to PackExpo this year, ... ago in Las Vegas,” said Jeff Williams, CEO at Avure. ... and we’re pleased to be meeting the challenges of market ...
(Date:10/30/2014)... Oct. 30, 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a company overview at the Nomura ... ET in Boston, MA. ... the "Investors & Media" section of the Company,s website, ... website within 48 hours and will be archived for a ...
Breaking Biology Technology:Rancho BioSciences Manually Curated TCGA Data Sets Available 2Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... INCOM Inc., the world,s leading commercial manufacturer of ... acquired Paradigm Optics, a manufacturer of polymer fiber optic ... intellectual property related to the manufacture and sale of ... capital equipment.  Paradigm Optics President & CEO Mr. David ...
... , part of Vocollect, a business unit of ... Pine Grove Nursing Center has implemented AccuNurse® voice ... care to patients and residents, while preparing for 2014 healthcare ... Grove CNAs to observe and accurately document care needs while ...
... Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: CEMI), which ... announced that Lawrence A. Siebert, President and Chief Executive ... Francisco at approximately 5:30 pm Eastern Time (2:30 pm ... The conference will be simultaneously webcast over the ...
Cached Biology Technology:INCOM Inc. Announces Acquisition of Paradigm Optics 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 2Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery 3Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3
(Date:10/31/2014)... his team have been studying the behavior of ... Alps for years. They observed that ravens slowly ... and playing. However, they also observed that these ... individual. Although in about 50 % of the ... the two affiliating ravens, intervening can be potentially ...
(Date:10/30/2014)... Mich. – When most animals begin life, cells immediately ... a vital organ. However, mammals, including humans, are special. ... different first choice – to become the protective placenta ... during this critical first step that research from Michigan ... in the current issue of PLOS Genetics ...
(Date:10/30/2014)... Carolina State University researchers have developed a suite of ... dogs and humans, which has applications in everything from ... pets. , "We,ve developed a platform for computer-mediated communication ... new avenues for interpreting dogs, behavioral signals and sending ... David Roberts, an assistant professor of computer science at ...
Breaking Biology News(10 mins):Identifying the source of stem cells 2New tech aims to improve communication between dogs and humans 2
... 2011) -- Scientists at Weill Cornell Medical College used genetic ... engineered for the study of cleft lip and cleft palate. ... treat the conditions in humans. Cleft lip and cleft ... requiring multiple cycles of surgery, speech therapy and orthodontics. To ...
... zoological journal ZooKeys published by Pensoft ... says an analysis dedicated to journal,s jubilee 150th issue, By ... 10,000 pages and 420 articles (to compare with 4,962 pages ... 2008, ZooKeys published more than 19,000 pages and ...
... has come from the fossil record, but how accurately does that ... "It,s a question that goes back a long way to ... tried to understand what it tells us about the history of ... In fact, the fossil record can tell us a great ...
Cached Biology News:Cleft lip corrected genetically in mouse model 2Cleft lip corrected genetically in mouse model 3Growth through innovations and open access: The journal ZooKeys on point for digital taxonomy 2Ancient environment led to Earth's current marine biodiversity 2